Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare conference being held January 8-11 in San Francisco. Tony J. Hunt, Chief Executive Officer, will present an overview of the company on Tuesday, January 9, 2024, at 2:15 p.m. PST.
Related news for (RGEN)
- Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
- Repligen Reports First Quarter 2025 Financial Results
- Repligen to Report First Quarter 2025 Financial Results
- Repligen Appoints Jacob Johnson As Vice President Investor Relations
- Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
